Search

everythinglearnresearchcommunity

for

Search:↓

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Managing multiple autoimmune diseases in one patient is very challenging.

CRPS type I is a complex pain condition with no proven cure, requiring personalized treatment.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

FFA and FAPD might be related or stages of the same disease.

A woman had meningitis caused by mixed connective tissue disease, not an infection.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

More research is needed to understand and treat morphea effectively.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Most patients with dermatomyositis had skin rash, itching, and muscle weakness, treated mainly with prednisolone and hydroxychloroquine.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

Careful diagnosis and management of MCTD are crucial due to potential severe complications.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Women with alopecia areata have poor blood flow, possibly due to nerve inflammation.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.